Peripheral blood TIM-3 Positive NK and CD8+ T cells throughout pregnancy: TIM-3/Galectin-9 interaction and its possible role during pregnancy

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Meggyes, Matyas ^a,b   Miko, Eva ^a,b   Polgar, Beata ^a,b   Bogar, Barbara ^a   Farkas, Balint ^b   Illes, Zsolt ^c,d   Szereday, Laszlo ^a,b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ECALECTIN; LYMPHOCYTE ANTIGEN; TIM 3 PROTEIN; UNCLASSIFIED DRUG; AUTACOID; CD56 ANTIGEN; CYTOKINE; GALECTIN; HAVCR2 PROTEIN, HUMAN; LGALS9 PROTEIN, HUMAN; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; PROTEIN BINDING;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NORMAL HUMAN; PREGNANCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY; BIOSYNTHESIS; BLOOD; DOWN REGULATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PHENOTYPE;

ADULT; ANTIGENS, CD56; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; FEMALE; GALECTINS; HUMANS; INFLAMMATION MEDIATORS; KILLER CELLS, NATURAL; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEINS; MIDDLE AGED; PHENOTYPE; PREGNANCY; PROTEIN BINDING;

EID: 84921532045     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092371     Document Type: Article

References (30)

1. Chaouat G (2007) The Th1/Th2 paradigm: still important in pregnancy? Seminars in immunopathology 29: 95-113. doi:10.1007/s00281-007-0069-0.
2. Sacks GP, Redman CWG, Sargent IL (2003) Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells. Clinical and experimental immunology 131: 490-497. (Pubitemid 36324141)
3. Southcombe J, Redman C, Sargent I (2010) Peripheral blood invariant natural killer T cells throughout pregnancy and in preeclamptic women. Journal of reproductive immunology 87: 52-59. doi:10.1016/j.jri.2010.07.003.
4. Borzychowski AM, Croy BA, Chan WL, Redman CWG, Sargent IL (2005) Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells. Eur J Immunol 35: 3054-3063. doi:10.1002/eji.200425929. (Pubitemid 41555101)
5. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6: 1123-1132. doi:10.1038/ni1254. (Pubitemid 41541790)
6. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG (1993) Synthesis of T helper 2-type cytokines at the maternal-fetal interface. Journal of immunology 151: 4562-4573. (Pubitemid 23318510)
7. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, et al. (2002) Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. doi:10.1038/415536a. (Pubitemid 34130609)
8. Zhao J, Lei Z, Liu Y, Li B, Zhang L, et al. (2009) Human pregnancy upregulates Tim-3 in innate immune cells for systemic immunity. Journal of immunology 182: 6618-6624. doi:10.4049/jimmunol.0803876.
9. Van de Weyer PS, Muehlfeit M, Klose C, Bonventre J V, Walz G, et al. (2006) A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochemical and biophysical research communications 351: 571-576. doi:10.1016/j.bbrc.2006.10.079. (Pubitemid 44666725)
10. Lee J, Su EW, Zhu C, Hainline S, Phuah J, et al. (2011) Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Molecular and cellular biology 31: 3963-3974. doi:10.1128/MCB.05297- 11.
11. Chabtini L, Mfarrej B, Mounayar M, Zhu B, Batal I, et al. (2013) TIM-3 regulates innate immune cells to induce fetomaternal tolerance. Journal of immunology 190: 88-96. doi:10.4049/jimmunol.1202176.
12. Wiersma VR, De Bruyn M, Helfrich W, Bremer E (2011) Therapeutic potential of Galectin-9 in human disease. Medicinal research reviews. doi:10.1002/med.20249.
13. Naka EL, Ponciano VC, Cenedeze MA, Pacheco-Silva A, Câmara NOS (2009) Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode. International immunopharmacology 9: 658-662. doi:10.1016/j.intimp. 2008.11.013.
14. Rabinovich GA, Liu F-T, Hirashima M, Anderson A (n.d.) An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer. Scandinavian journal of immunology 66: 143-158. doi:10.1111/j.1365-3083.2007.01986.x.
15. Seki M, Oomizu S, Sakata K-M, Sakata A, Arikawa T, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clinical immunology 127: 78-88. doi:10.1016/j.clim.2008.01.006.
16. Zhu C, Anderson AC, Schubart A, Xiong H, Imitola J, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6: 1245-1252. doi:10.1038/ni1271. (Pubitemid 43045636)
17. Sabatos CA, Chakravarti S, Cha E, Schubart A, Sánchez-Fueyo A, et al. (2003) Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat Immunol 4: 1102-1110. doi:10.1038/ni988. (Pubitemid 37428038)
18. Oomizu S, Arikawa T, Niki T, Kadowaki T, Ueno M, et al. (2012) Cell surface galectin-9 expressing th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion. PloS one 7: e48574. doi:10.1371/journal.pone.0048574.
19. Shimizu Y, Kabir-Salmani M, Azadbakht M, Sugihara K, Sakai K, et al. (2008) Expression and localization of galectin-9 in the human uterodome. Endocrine journal 55: 879-887.
20. Von Wolff M, Wang X, Gabius H-J, Strowitzki T (2005) Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Molecular human reproduction 11: 189-194. doi:10.1093/molehr/gah144. (Pubitemid 40662752)
21. Popovici RM, Krause MS, Germeyer A, Strowitzki T, Von Wolff M (2005) Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans. The Journal of clinical endocrinology and metabolism 90: 6170-6176. doi:10.1210/jc.2004-2529. (Pubitemid 41606540)
22. Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, et al. (2003) Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 4: 1093-1101. doi:10.1038/ni987. (Pubitemid 37428037)
23. Miko E, Manfai Z, Meggyes M, Barakonyi A, Wilhelm F, et al. (2010) Possible role of natural killer and natural killer T-like cells in implantation failure after IVF. Reproductive biomedicine online 21: 750-756. doi:10.1016/j.rbmo.2010.07.012.
24. Kwak-Kim J, Gilman-Sachs A (2008) Clinical implication of natural killer cells and reproduction. American journal of reproductive immunology 59: 388-400. doi:10.1111/j.1600-0897.2008.00596.x.
25. Golden-Mason L, McMahan RH, Strong M, Reisdorph R, Mahaffey S, et al. (2013) Galectin-9 functionally impairs natural killer (NK) cells in humans and mice. J Virol 87: 4835-4845. doi:10.1128/JVI.01085-12.
26. Rabinovich GA, Toscano MA (2009) Turning "sweet" on immunity: galectinglycan interactions in immune tolerance and inflammation. Nature reviews Immunology 9: 338-352. doi:10.1038/nri2536.
27. Blidner AG, Rabinovich GA (2013) "Sweetening" Pregnancy: Galectins at the Fetomaternal Interface. American journal of reproductive immunology 69: 369-382. doi:10.1111/aji.12090.
28. Mengshol JA, Golden-Mason L, Arikawa T, Smith M, Niki T, et al. (2010) A crucial role for Kupffer cell-derived galectin-9 in regulation of T cell immunity in hepatitis C infection. PloS one 5: e9504. doi:10.1371/journal.pone. 0009504.
29. Klibi J, Niki T, Riedel A, Pioche-Durieu C, Souquere S, et al. (2009) Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. Blood 113: 1957-1966. doi:10.1182/blood-2008-02-142596.
30. Than NG, Romero R, Kim CJ, McGowen MR, Papp Z, et al. (2011) Galectins: guardians of eutherian pregnancy at the maternal-fetal interface. Trends in endocrinology and metabolism: TEM 23: 23-31. doi:10.1016/j.tem.2011.09.003.